A good week for taking profits, but a 2p fall in
OPTI:Optibiotix spoiled what would have been a great performance. The
deficit between cost and value widened by £2,956 but I cashed in £1,667 of
profits. The deficit now stands at £28,825 and total portfolio value at
£95,327.
There were no big fallers this week.
JLP:Jubilee Metals continued recent good form and climbed another 5%
this week, and I did take advantage to top-slice some from my ISA. I still
hold 100,000 shares though, which I'll keep long term.
FXPO:Ferrexpo reversed the recent slump and climbed 8% to go back into profit, albeit only by 1%, but it would be 7% if you include the £65 dividends.
TRMR:Tremor published great results and gained another 8% to put them only 27% down now. I'm starting to feel I may be able to get rid of them at some point soon.
Share of the Week is TLOU:Tlou Energy which only just missed out last week, but which is rising steadily and went up another 11% this week. They are now 47% down which is quite a lot, but if this momentum can be maintained I could be back in profit soon. I still want to hold these long term as I like what they are doing.
Hardly any drop in value, but a tick up in cost so the deficit grew.
The trend line is finally pointing upwards, but we are only just above it.
The ISA and share portfolios look like this
| Weekly Change | |||
| Cash |
£13.45 |
-£19.78 | |
| Portfolio cost | £62,990.04 | +£867.36 | |
| Portfolio sell value (bid price-commission) | £46,972.00 | (-25.4%) | -£1,831.84 |
| Potential profits | £2,072.05 | -£575.23 | |
| Yr 6 Dividends | £0 | +£0 | |
| Yr 6 Profit from sales | £591.81 | +£835.62 | |
| Yr 6 Average monthly cash profit | £209.65 | (4.0%) | +£310.13 |
| Total Dividends | £1,343.15 | +£0 | |
| Total Profit from sales | £21,018.42 | +£835.62 | |
| Average monthly cash profit | £352.36 | (6.7%) | +£12.06 |
|
(Sold stocks profit + Dividends - Fees / Months) |
|||
| Performance/Injection | 10.1% | +0.3% | |
| Compound performance | 53% | +2% |
I sold 42,149 shares of JLP:Jubilee Platinum at 6.4p making £835.62 (44.8%) profit and liberating £2,685.59. That still leaves me with 100,000 shares, but with JLP's history of volatility and the fact I've been worried for a while that I'd invested too much in a higher risk company, it felt prudent to reduce my exposure.
I also wanted to get some more OPTI:Optibiotix, as I always do when the
share price drops inexplicably despite all the amazing news and imminent
profits. I bought 4,915 shares at 54.8p costing £2,705.37. That puts my total
holding at 122,238 shares at an average price of 63.6p costing £78,205.08.
Every 1p change is now worth £1,222. Unfortunately their sell value is
currently 51p so I'm down by £15,899! I'm in this one for the long haul
though.
Potential profits only dropped by £575 because JLP:Jubilee Metals increased in value compared to last week, and my year 6 performance was negative last week but went positive this week, and improved my overall performance by 0.3% against injection value to put me above my 10% target.
Overall value dropped by £1,831 which I think of as a small fall these days.
Still a reasonable buffer down to the injection line
The trend line is pointing more strongly upwards and we're still above it, so I'm happy.
The SIPP looks like this after week 256
| Weekly Change | ||||
| Cash | £110.00 | +£79.86 | ||
| Portfolio cost | £58,449.25 | +£722.68 | ||
|
Portfolio sell value (bid price - commission) |
£46,375.75 | (-20.7%) | -£1,230.60 | |
| Potential profits | £163.85 | -£622.16 | ||
| Yr 5 Dividends | £162.58 | +£0 | ||
| Yr 5 Interest | £0.03 | +£0 | ||
| Yr 5 Profit from sales | £2,910.34 | +£722.54 | ||
| Yr 5 Average monthly cash profit | £262.89 | (5.4%) | +£61.02 | |
| Total Dividends | £2,061.82 | +£0 | ||
| Total Interest | £0.20 | +£0 | ||
| Total Profit from sales | £15,459.44 | +£722.54 | ||
| Average monthly cash profit | £286.36 | (5.9%) | +£11.16 | |
|
(Sold stocks profit + Dividends - Fees / Months) |
||||
| Performance/Injection | 9.2% | +0.4% | ||
| Compound performance | 45% | +2% |
I sold the rest of my holding in DDDD:4D Pharma when they had a rebound from their recent slump. I decided that although they are doing amazing things, it's so long until they are going to be profitable that it's likely to be a painful and frustrating journey, and I'd rather watch from the sidelines and potentially jump on board when the price drops if they need a placing, or just buy after an increase and make less profit but avoid the stress of supporting another startup company pre-profits.
I sold 1,500 shares for 97.83p making £722,54 (96.9%) profit. My short investment here was really good as it's given me £2,258 profit and allowed me to significantly increase my holding in SBTX:SkinBioTherapeutics as well as get back into gold with CMCL:Caledonia Mining. The sale liberated £1,455.50 and I used it to buy another 8,418 shares in SBTX:SkinBioTherapeutics at 17.15p costing £1,455.64. That brings my total holding to 23,081 at an average price of 17.22p costing £4,011.84. I've achieved my ambition of holding more than I ever have before. I now have to decide how brave I'm going to be in trading them as I really want to be a long term holder. The benefit of having so many is I can sell half of them and still have more than 10,000 so I never need to be completely out of them again, which is a nice position to be in.
Cash increased a little as I had a tax rebate of £80, profits dropped less than I cashed in as there were rises in some other shares and APAX:Apax Global Alpha, FXPO:Ferrexpo, ITV:ITV and POLR:Polar Capital Holdings are all in profit.
Annual performance almost caught up with long term performance, and long term
performance against injection amount improved by 0.4% to go above 9% and not
far off my 10% target.
Cost is going up but unfortunately value isn't. We're back below the halfway point between the injection line and the cost line which is troubling.
The trend line is only just downwards now, but we're resting on it so that's not going to help.
The trading account looks like this after week 222
| Weekly Change | |||
| Cash | £236.18 | +£8.39 | |
| Portfolio cost | £2,354.11 | +£0.48 | |
| Portfolio sell value (bid price - commission) | £1,620.49 | (-31.2%) | +£106.18 |
| Potential profits | £0 | +£0 | |
| Year 5 Dividends | £0 | +£0 | |
| Year 5 Profit | £370.12 | +£108.89 | |
| Yr 5 Average monthly cash profit | £114.56 | (58.4%) | +£27.48 |
| Dividends | £47.92 | +£0 | |
| Profit from sales | £656.49 | +£108.89 | |
| Average monthly cash profit | £13.75 | (7.0%) | +£2.07 |
|
(Sold stocks profit + Dividends - Fees / Months) |
There was a flurry of excitement last thing on Friday when DDDD:4D Pharma put on a bit of a spike and cleared £100 profit. That's my signal to sell, so I collected £108 and withdrew £100 back into my bank account to reduce the injection amount to £1,800. I snapped up a bargain 3,030 shares in SBTX:SkinBioTherapeutics at 16.5p right on the closing bell costing £511.90 as I'm fairly convinced these are due a bounce back above 20p soon.
My year 5 performance is fairly staggering at £114 a month, but it's projected and only
based on 14 weeks, so I doubt I'll keep that up all year. Long term
performance improved to 7% at £13.75 a month, so it's starting to look much
more respectable and much better than being in a building society. I just need
the other 4 companies that are languishing at a loss to buck up their ideas,
as I'm effectively trading on one £500 pot at the moment.
It was also a great week for those other shares as value increased by £106
despite taking all my profits.
Nice to see value is above injection amount now, despite taking profits.
Well above the trend line which is getting steeper every week.
Here's my wish list
- TLOU:Tlou Energy announce de-watering has resumed. Still no news of this. I've been reporting that the price is still sneaking up every week, and this week the increase has started to accelerate. I'm now anticipating news of a new major holder as the buying is relentless. Somebody with a lot of money can see value here.
- JLP:Jubilee Metals to announce permission to process platinum rich tailings at DCM and the fine chrome plant move is completed and operational. Neither have happened yet, but we must be getting really close.
-
OPTI:Optibiotix to get within 10% of profit. Nope - the opposite,
dropping further and even dropping more after I topped up. If it stays at
this level for another month, I'll be using all of my £2,000 pension
transfer to buy more, as I've got 7 of my magic formula shares already,
which is ahead of schedule so I'm allowed a little leeway.
- CAML:Central Asia Metals re-instate their dividend. Surely this has got to happen soon?
No comments:
Post a Comment